Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2–induced lung exudative vasculitis and predicts COVID-19 severity
Chiaki Iwamura, Kiyoshi Hirahara, Masahiro Kiuchi, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 33
Open Access | Times Cited: 21

Showing 21 citing articles:

Emerging functions of thrombospondin-1 in immunity
Sukhbir Kaur, David D. Roberts
Seminars in Cell and Developmental Biology (2023) Vol. 155, pp. 22-31
Open Access | Times Cited: 28
Prolonged high Myl9 levels are associated with the pathogenesis and respiratory symptom of post-acute COVID-19 syndrome: A 6-month follow-up study
Jun Sugihara, Chiaki Iwamura, Tomoya Tateishi, et al.
Clinics (2025) Vol. 80, pp. 100584-100584
Open Access
Toxicity-specific peripheral blood T and B cell dynamics in anti-PD-1 and combined immune checkpoint inhibition
Mick J M van Eijs, Rik J. Verheijden, Stefanie A. van der Wees, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 12, pp. 4049-4064
Open Access | Times Cited: 14
Serum VEGF-A levels on admission in COVID-19 patients correlate with SP-D and neutrophils, reflecting disease severity: A prospective study
Mayoko Tsuji, Mitsuko Kondo, Yasuto Sato, et al.
Cytokine (2024) Vol. 178, pp. 156583-156583
Open Access | Times Cited: 2
Suppression of Type I Interferon Signaling in Myeloid Cells by Autoantibodies in Severe COVID-19 Patients
Ami Aoki, Chiaki Iwamura, Masahiro Kiuchi, et al.
Journal of Clinical Immunology (2024) Vol. 44, Iss. 4
Open Access | Times Cited: 2
Increased Myosin light chain 9 expression during Kawasaki disease vasculitis
Hironobu Kobayashi, Motoko Y. Kimura, Ichita Hasegawa, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 7
Comparative spatial transcriptomic profiling of severe acute respiratory syndrome coronavirus 2 Delta and Omicron variants infections in the lungs of cynomolgus macaques
Taehwan Oh, Green Kim, Seung Ho Baek, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Open Access | Times Cited: 5
Prediction of oxygen supplementation by a deep-learning model integrating clinical parameters and chest CT images in COVID-19
Naoko Kawata, Yuma Iwao, Yukiko Matsuura, et al.
Japanese Journal of Radiology (2023) Vol. 41, Iss. 12, pp. 1359-1372
Open Access | Times Cited: 5
Unveiling the Pathological Mechanisms of Death Induced by SARS-CoV-2 Viral Pneumonia
George-Călin Oprinca, Cosmin-Ioan Mohor, Alexandra Oprinca-Muja, et al.
Microorganisms (2024) Vol. 12, Iss. 3, pp. 459-459
Open Access | Times Cited: 1
Increased levels of circulating cell-free DNA in COVID-19 patients with respiratory failure
Akihiko Tanaka, Katsuki Wakayama, Y Fukuda, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Pathogenic helper T cells as the novel therapeutic targets for immune-mediated intractable diseases
Atsushi Onodera, Kota Kokubo, Mikiko Okano, et al.
Pharmacology & Therapeutics (2023) Vol. 247, pp. 108445-108445
Open Access | Times Cited: 4
Thrombosis and Hyperinflammation in COVID-19 Acute Phase Are Related to Anti-Phosphatidylserine and Anti-Phosphatidylinositol Antibody Positivity
Jaume Alijotas‐Reig, Ariadna Anunciación-Llunell, Stephanie Morales-Pérez, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2301-2301
Open Access | Times Cited: 4
Effect of coronaviruses on blood vessel permeability: potential therapeutic targets
Nicolle Rakanidis Machado, Karina T. Dias, Bryan F.S. Cortes, et al.
Therapeutic Advances in Respiratory Disease (2023) Vol. 17
Open Access | Times Cited: 3
SARS-CoV-2 and Its Bacterial Co- or Super-Infections Synergize to Trigger COVID-19 Autoimmune Cardiopathies
Robert Root‐Bernstein, Jack Huber, Alison Ziehl, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12177-12177
Open Access | Times Cited: 2
Clinical and Genetic Markers of Vascular Toxicity in Glioblastoma Patients: Insights from NRG Oncology RTOG-0825
J Strauss, Mark R. Gilbert, Minesh P. Mehta, et al.
Neuro-Oncology (2024)
Closed Access
Clinical characteristics of coronavirus disease 2019 in patients undergoing laparoscopic bariatric/metabolic surgery: a nationwide survey in Japan
Yasuhiro Miyazaki, Masayuki Ohta, Seiichi Kitahama, et al.
Surgery Today (2024)
Closed Access
Bulk and Single-Cell RNA Sequencing Elucidate the Etiology of Severe COVID-19
Łukasz Huminiecki
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3280-3280
Open Access
Bulk and Single-Cell RNA-seq Elucidates Etiology of Severe COVID-19
Łukasz Huminiecki
(2023)
Open Access | Times Cited: 1
Serum VEGF Levels on Admission in COVID-19 Patients Correlate with SP-D and Neutrophils, Reflecting Disease Severity: A Prospective Study
Mayoko Tsuji, Mitsuko Kondo, Yasuto Sato, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Validation of a specialized evaluation system for COVID-19 in Japan: A retrospective, multicenter cohort study
Hiroki Furuhata, Kenji Araki
Journal of Infection and Chemotherapy (2022) Vol. 29, Iss. 3, pp. 294-301
Open Access
Page 1

Scroll to top